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Objectives: The aim of this study was to analyze the changes in hemoglobin level and to determine a
suitable timeline for post-operative hemoglobin monitoring in patients undergoing ﬁxation of femoral
neck fracture.
Patients and methods: Patients who underwent either dynamic hip screw (DHS) ﬁxation (n ¼ 74, mean
age: 80 years) or hip hemiarthroplasty (n ¼ 104, mean age: 84 years) for femoral neck fracture were
included into the study. The hemoglobin level of the patients was monitored perioperatively.
Results: Analysis found a statistically and clinically signiﬁcant mean drop in hemoglobin of 31.1 g/L over
time from pre-operatively (D0) to day-5 post-operatively (p < 0.001), with signiﬁcant reductions from D0
to day-1 and day-1 to day-2 (p < 0.001). At each post-operative time point, DHS patients had lower
hemoglobin values over hemiarthroplasty patients (p ¼ 0.046).
Conclusion: The decrease in hemoglobin in the ﬁrst 24-h post-operative period (D0 to day-1) is an
underestimation of the ultimate lowest value in hemoglobin found at day-2. Relying on the day-1 he-
moglobin could be detrimental to patient care. We propose a method of predicting patients likely to be
transfused, and recommend a protocol for patients undergoing femoral neck fracture surgery to stan-
dardize postoperative hemoglobin monitoring.
Level of evidence: Level IV Prognostic study.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Postoperative hemoglobin analysis for orthopedic patients ex-
pected to have lost signiﬁcant volumes of blood during surgery is
part of good medical practice. Therefore, it is often routine care to
measure the hemoglobin levels on Day 1 after surgery (D1, [within
24 h of surgery, subsequent 24 h periods are deﬁned as D2, D3 and
so forth]). However, the timing of subsequent analyses is not well
deﬁned in the literature.
Surgery for fractured neck of femur (NOF) is one of the most
common orthopedic procedures performed in hospitals worldwide
today.1,2 Generally occurring among elderly,3 fractured NOF is
associatedwith highmorbidity (approximately 50%)4 andmortality
(33%)5 rates in one year. The guidelines of the National Institute for
Health and Care Excellence (NICE) recommend that surgery for
fractured NOF be performed between 24 and 48 h after admission).
ciation of Orthopaedics and
s and Traumatology. Publishing sefollowing medical optimization and multidisciplinary input, based
on the National Hip Fracture Database (NHFD) which suggests a 36-
h window.6
Low pre- and postoperative hemoglobin are recognized factors
that affect length of stay, transfusion risk, morbidity and mortal-
ity.7e16 However, as of 2014, a review of the peer-reviewed litera-
ture revealed that no recommendations exist regarding an
optimum perioperative hemoglobin level. In addition, in the UK,
there are currently no recommendations regarding the timeframe
within which postoperative hemoglobin should be taken.17 A study
at our own institution revealed inconsistent postoperative blood
sampling practice of hip fracture patients, with some patients
having daily blood sampling as default.
An evidence-based protocol could optimize this patient group's
recovery and reduce the cost for the National Health Service (NHS,
UK). Therefore, we investigated pre- and postoperative hemoglobin
to establish a perioperative hemoglobin analysis regime for pa-
tients undergoing routine ﬁxation of fractured NOF with a view to
efﬁcaciously assess for anemia.rvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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A prospective study of all NOF fractures surgically managed over
an 18-month period was conducted at our institution. The Research
and Ethics Committee approved the study and associated protocols
(reference: 12/NW/0400). A total of 390 patients were admitted for
surgical management of a fractured NOF during this study period.
178 patients (74 dynamic hip screw for intertrochanteric fractures
[DHS] and 104 hemiarthroplasty, both monopolar and bipolar
hemiarthroplasty for femoral neck fractures) were eligible for
analysis after the application of the exclusion criteria described in
Table 1.
Sensible assumptions have been made for the purposes of this
study. The same technique was used for monopolar and bipolar
hemiarthroplasty surgery; only the implant used for each of the
two techniques was different. It is therefore reasonable to combine
their data. Also, hemoglobin values during the perioperative period
are a recognized measure of blood volume and/or blood loss. Blood
loss parameter may therefore be used to describe our results. All
patients received the same low-molecular weight heparin anti-
coagulation regimen unless contraindicated. Drains were not
routinely inserted.
For 68% of the patients, hemoglobin levels were measured
preoperatively (D0) and on at least two consecutive postoperative
days while the other 32% had their hemoglobin levels monitored on
at least two non-consecutive postoperative days. No protocol was
in place to instruct clinicians on when to monitor hemoglobin
levels. The decrease in hemoglobin was calculated by subtracting
the hemoglobin level on the studied postoperative day from the
level on the preoperative day.
A repeated measures General Estimation Equation (GEE) model
was employed for any omitted hemoglobin values with day (D) as
the factor to assess for the overall trend in hemoglobin levels over
time (Fig. 1). Pairwise comparisons between days were assessed
and signiﬁcances were adjusted using a quasi-Bonferroni correc-
tion for multiple testing by applying a lower critical value of 0.01
(1% signiﬁcance level) for pairwise p values. Adjusted means were
comparable between time points despite variance in numbers of
non-missing outcome measures due to use of the GEE model.
Dynamic hip screw and hemiarthroplasty patients were
compared for hemoglobin values over time. In addition, hemoglo-
bin levels were compared between patients undergoing prompt
surgery (surgery commenced within 36 h of admission) with pa-
tients who had delayed surgery for a non-medical cause (between
36 and 72 h from admission).
The GEE models investigated the differences between surgical
procedures ﬁtted with factors including numbers of days since
admission, type of surgical procedure and interaction, and inﬂu-
ence of delay to commencing surgery and those ﬁtted with factors
including numbers of days since admission, type of surgical pro-
cedure and surgery delay.
Additionally, hemoglobin blood loss by D2 was assessed using
analysis of covariance (ANCOVA) models. The analyses of D2 he-
moglobin values included predictors for D0 hemoglobin, type of
surgical procedure, and surgery delay. Changes in hemoglobinTable 1
Exclusion criteria for study.
1. Patients with associated injuries
2. Patient age 50 years
3. Surgical repair other than DHS/hemiarthroplasty
4. >72 h time to surgery
5. <2 Postoperative Hb readings during admission
6. Patients requiring perioperative transfusionfrom D0 to D2 were calculated from the adjusted means from the
ANCOVA model.
Overall analysis used a conventional two-sided 5% signiﬁcance
level, and pairwise comparisons were adjusted for multiple com-
parisons using a two-sided 1% signiﬁcance level. All analyses were
produced using SPSS Statistics (Version 20.0, IBM Corp).
Results
The mean age of the patient cohort was 83 years (DHS 80.5,
hemiarthroplasty 84.4; range: 58e98 years, standard deviation
[SD]: 10 years) and preoperative hemoglobin was 126.3 g/L (range:
93e168 g/L, SD: 12.9 g/L).
There were signiﬁcant reductions in hemoglobin over time
(p < 0.001). Speciﬁcally, the drop in hemoglobin values between
the preoperative period and the lowest adjusted mean value on D5
was 31.1 g/L.
The D0 hemoglobin values had a highly signiﬁcant inﬂuence on
hemoglobin changes by D2 (p < 0.001), after adjusting for type of
surgeryand surgical delay. Hemoglobinvalues dropped signiﬁcantly
from D0 (mean 126.3 g/L) to D1 (101.5 g/L) by 24.8 g/L (p < 0.001).
Postoperatively, a further signiﬁcant fall of 4.4 g/L in hemoglobin
(p < 0.001) was also noted between D1 and D2 (97.1 g/L). However,
there were no statistically signiﬁcant changes from D2 to D3
(p¼ 0.131), D3 to D4 (p¼ 0.881), and D4 to D5 (p¼ 0.483) (Table 2).
Comparison between surgical procedures showed statistically
signiﬁcant differences in hemoglobin between types of surgeries
(p ¼ 0.046) over all time points. DHS patients consistently had
lower average hemoglobin values than hemiarthroplasty patients
(Table 3). The average changes from D0 to D5 were 31.7 g/L for DHS
and 30.6 g/L for hemiarthroplasty.
For both DHS and hemiarthroplasty, the drop was greatest on
the ﬁrst two postoperative days, after adjusting for D0 values and
surgical delay (Table 5). DHS patients had 4.6 g/L greater mean
hemoglobin reduction compared to hemiarthroplasty patients
(p ¼ 0.043, 95% conﬁdence interval [CI] 9.12, 0.15 g/L), with the
hemoglobin values decreased the most from D0 to D1.
The trend of hemoglobin changes over time showed no statis-
tically signiﬁcant differences between either forms of surgery
(p ¼ 0.414). Therefore, although the decrease in hemoglobin was
greater fromD0 for DHS, the pattern of changewas similar between
types of surgery.
There were no statistically signiﬁcant differences in hemoglobin
levels for surgical delay (p ¼ 0.389) (Table 4), after adjusting the
number of days since admission and type of surgery (Fig. 2).
The decrease in hemoglobin from D0 values was greatest until
D2; hence further detailed analysis was conducted for this time
period.
Discussion
Although expeditious surgery for patients with hip fractures has
beneﬁts for patient recovery and return to function, we are unable
to beneﬁt from postoperative hemoglobin values. Patients with
dynamic hip screw ﬁxation lose more blood overall (and certainly
within the ﬁrst two days postoperatively) but this is not affected by
prompt surgery. If surgery occurs within 72 h of the ﬁrst hemo-
globin reading, then repeating this preoperatively is unnecessary.
The results show a mean hemoglobin decrease of 31.1 g/L for all
patients over ﬁve days from surgery. Interestingly, our study
showed that the drop in hemoglobin continues until D5, however,
decreases between consecutive days were only signiﬁcant until D2.
Thus, we recommend D2 for the most timely analysis and subse-
quent management of postoperative hemoglobin. Our analysis in
bleeding kinetics within acute fractured NOF patients is in parallel
Fig. 1. (A) Scatter plot of hemoglobin values with locally weighted scatterplot smoothing best-ﬁt curve. (B) Average hemoglobin values with 95% conﬁdence intervals.
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globin in elective lower limb arthroplasty.18 The group also showed
that the most signiﬁcant bleeding loss occurred between the end of
surgery and D1; however, the fall in hemoglobin ceased by D3. It is
reasonable to assume that the observed decrease in hemoglobin is
caused by varying contributions from bleeding from the woundTable 2
Changes in Hb in the perioperative period from Day 0 (preoperatively) until Day 5.
Predicted Hb values from GEE model over time
Day n-value Hb
Pre-op (Day 0) 178 126
Day 1 166 101
Day 2 114 97.1
Day 3 69 95.8
Day 4 76 95.9
Day 5 49 95.2site, bleeding into soft tissues, loss in drains and the dilutive effect
of postoperative ﬂuids. More complex pathological processes such
as decreased erythropoiesis secondary to a large inﬂammatory
response from surgery, and decreased intestinal absorption and
mobilization of iron also contribute to the postoperative hemo-
globin drop.19,20adjusted mean (g/L) 95% conﬁdence interval (g/L)
.3 124.4, 128.2
.5 99.6, 103.5
95.0, 99.3
93.5, 98.1
93.8, 98.1
92.8, 97.6
Table 3
Changes in Hb in the perioperative period by type of surgical repair.
Hb results from GEE model for surgery type grouping
Surgery type grouping Day n-value Hb adjusted mean (g/L) 95% conﬁdence interval (g/L)
DHS Pre-op 74 125.0 121.9, 128.1
Day 1 68 99.5 96.4, 102.6
Day 2 49 93.9 90.6, 97.2
Day 3 32 93.9 90.3, 97.5
Day 4 28 94.0 90.1, 97.8
Day 5 23 93.3 89.9, 96.7
Hemiarthroplasty Pre-op 104 127.3 124.9, 129.6
Day 1 98 102.9 100.4, 105.4
Day 2 65 99.6 96.7, 102.4
Day 3 37 96.9 94.1, 99.8
Day 4 48 97.3 94.7, 99.8
Day 5 26 96.7 93.4, 99.9
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aware that the patient's preoperative hemoglobin should be able to
withstand a minimum of 31.1 g/L drop. When considering the up-
per and lower limits of the 95% conﬁdence intervals of D0 and D2
respectively, a preoperative hemoglobin level of 40 g/L above the
institution's transfusion trigger value (TTV) is recommended to
allow for predicted drop in hemoglobin and to avoid transfusion.
This level can be achieved by preoperative transfusion and iron
replacement (with or without erythropoietin) with decisions made
on a case-by-case basis.
Further justiﬁcation for the surgical prerequisite stems from
previous studies, which suggest that a low D0 hemoglobin in-
creases the necessity of transfusion (and its associated risks),12 in
addition to increased morbidity and mortality. Halm et al showed
that patients with higher preoperative hemoglobin had a shorter
length of stay, lower morbidity and readmission within 60 days of
discharge.7 Gruson et al followed 395 patients above the age of 65,
and similarly found that hospital length of stay and mortality at six
months and twelve months postoperatively were higher for pa-
tients with a preoperative anemia.8 In fact, it was shown thatTable 4
Analysis of changes in Hb levels in the perioperative period. No statistically signiﬁcant ch
after adjusting for day of Hb levels and type of surgical repair.
Hb results from GEE main effects model
Surgery type grouping Surgery delay Day n-va
DHS 0e1 day Pre-op 54
Day 1 50
Day 2 35
Day 3 20
Day 4 20
Day 5 17
2e3 days Pre-op 20
Day 1 18
Day 2 14
Day 3 12
Day 4 8
Day 5 6
Hemiarthroplasty 0e1 day Pre-op 71
Day 1 66
Day 2 45
Day 3 26
Day 4 29
Day 5 20
2e3 days Pre-op 33
Day 1 32
Day 2 20
Day 3 11
Day 4 19
Day 5 6patients were twice as likely to die in hospital compared to non-
anemic patients (odds ratio: 2.0, p ¼ 0.3). This trend is echoed by
a study by Ho et al who found that a preoperative hemoglobin of
less than 110 g/L was associated with increased mortality at 12
months.9 Importantly, one of the most commonly used and reliable
predictors of mortality post hip fracture ﬁxation surgery,21 the
Nottingham Hip Fracture Score speciﬁcally includes preoperative
hemoglobin in its mortality predicting score due to the high asso-
ciation with mortality.10
This study demonstrated that a hemoglobin value taken on D2
postoperatively represents the largest drop in a patient's circu-
lating hemoglobin with statistical and also clinical signiﬁcance.
We can conclude that D1 postoperative hemoglobin values may
provide false reassurance to clinicians monitoring patients who
have undergone a fractured NOF procedure. The evidence shows
that the hemoglobin value might be above the TTV on D1, but may
fall below TTV due to the continued and signiﬁcant fall in he-
moglobin. In effect, a hemoglobin value measured on D1 might
provide false assurance to the clinician andwill have fallen further
on D2.anges in Hb were observed when comparing prompt surgery with a 36e72 h delay,
lue Hb adjusted mean (g/L) 95% conﬁdence interval (g/L)
124.0 120.9, 127.1
99.2 96.1, 102.3
94.8 91.6, 98.1
93.5 90.2, 96.8
93.6 90.2, 97.0
93.0 89.7, 96.3
125.5 122.1, 128.9
100.7 97.4, 104.0
96.3 92.8, 99.8
95.0 91.2, 98.7
95.1 91.4, 98.7
94.5 90.7, 98.3
127.2 124.7, 129.7
102.4 99.8, 105.0
98.0 95.3, 100.8
96.7 93.9, 99.4
96.8 94.2, 99.4
96.2 93.3, 99.0
128.7 125.5, 131.8
103.8 100.7, 107.0
99.5 96.2, 102.7
98.1 94.6, 101.7
98.3 95.1, 101.5
97.6 94.0, 101.3
Table 5
Analysis of changes in Hb levels from D0 to D2. Statistically signiﬁcant changes in Hb using the ANCOVA model are observed between D0 and D2 after adjusting for D0 Hb
levels, type of surgery and surgical delay.
Surgery type grouping Day n-value Hb adjusted mean (g/L) 95% conﬁdence interval (g/L)
DHS Day 2 49 93.73 90.21, 97.25
Change from pre-op 32.70 36.22, 29.18
Hemiarthroplasty Day 2 65 98.36 95.27, 101.45
Change from pre-op 28.07 31.16, 24.98
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(7.9%) who had a ‘falsely high’ hemoglobin value on D1, which
subsequently fell further on D2 to below the TTV value. However,
7.9% is probably fairly conservative considering that these 14 pa-
tients were within the 102 patients who had both their blood
samples taken on D1 and D2.
Looking at speciﬁc values, the data shows that the statistically
signiﬁcant fall in hemoglobin between D1 and D2 is on average
from 101.5 g/L (95% CI 99.6, 103.5 g/L) to 97.1 g/L (95% CI 95.0,
99.3 g/L) for all ﬁxations of NOF fractures. This decrease traverses
the value of 100 g/L which is typically the threshold for anemia.22
This threshold was also historically relevant for transfusions,23
however, with increased awareness of risks associated with trans-
fusion, more restrictive transfusion policies are now favored.
Despite this, patients with symptomatic anemia with a hemoglobin
of less than 100 g/L are still recommended to have a transfusion.24
Furthermore, it can be concluded that the average patient un-
dergoing NOF fracture ﬁxation becomes anemic on D2 and not D1.
This adds further weight behind the idea of routinely testing the
patients on D2 postoperatively and not D1. If D2 hemoglobin level is
more sensitive for anemia, affected patients can be reliably iden-
tiﬁed and commenced on appropriate measures to restore theirFig. 2. A graphical representation of hemoglobin levels in the periohemoglobin to acceptable levels. This is important because anemic
patients are more likely to require a transfusion if their hemoglobin
is not managed well.25,26
Orthopedic surgeons should highly consider the importance
of the limitations anemic patients might have whenworking with
rehabilitation services. Young et al described that patients feeling
the lethargic effect of anemia may well have a reduced functional
status resulting in an increased time to discharge and potentially
a higher infection rate postoperatively.27 Lawrence et al showed
that higher hemoglobin levels postoperatively were associated
with increased functional status as measured by walking dis-
tance.28 Dunne et al found that patients who were anemic
postoperatively (deﬁned by a hematocrit less than 36) had
increased mortality, incidence of pneumonia and length of hos-
pital stay.29
A hemoglobin level of less than 100 g/L has been shown to be
associated with the increased likelihood of wound infection rates in
vascular surgery30 and this trend has also been conﬁrmed in total
joint arthroplasty.31 Early intervention in treating low hemoglobin
was shown to reduce postoperative transfusion frequency and
number of units in addition to postoperative infection rates in or-
thopedic patients.19,32 Collectively, this research adds signiﬁcantperative period divided by type of surgery and surgical delay.
Table 6
Deﬁning factors for an ‘At Risk’ patient.
‘At Risk’ groups:
1. Patients with a pre-operative Hb level of <32 g/L above the centres TTV
2. Patients taking any form of anticoagulation
3. Patients with underlying chronic renal, cardiac disease
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order to predict, detect and treat anemia promptly.7e16
Jointly, the resource and subsequent ﬁnancial burden of hip
fracture surgery is signiﬁcant. The estimated cost of collecting,
transporting and processing a single full blood count sample is £633
e individually this may appear to be an insigniﬁcant sum, however
when considering the number of patients undergoing hip fracture
surgery (currently approximately 70,000 per year projected to in-
crease to 101,000 in 2020) in the context of an ageing population,
the ﬁnancial burden runs into thousands of pounds per year per
center and this value is set to increase.34 Moreover, after consid-
eration of the risks associated with the practice of phlebotomy,
including, but not limited to, bruising/hematoma, phlebitis/
bacteremia and needle stick injuries, a greater evidence base should
be employed to make decisions about postoperative blood testing.
Therefore, a protocol for efﬁcacious blood sampling would
reduce the number of samples required for hemoglobin analysis, in
turn reducing the risk on patient and practitioner.
Evidence has shown that certain groups will require close
-daily- monitoring of hemoglobin levels. Carson et al have previ-
ously shown that surgical patients with cardiovascular disease have
a greater incidence of morbidity and mortality if they had a he-
moglobin level of 100 g/L or less.35 With regards to chronic disease
in the elderly population, patients with chronic renal impairment
have been shown to have an increased incidence of transfusion in
the perioperative period36 and so this group should also be given
special consideration. With regards to this study, patients taking
some form of anticoagulation were excluded due to the fact that
this subpopulation will intrinsically have signiﬁcant comorbidities
and should therefore be monitored on an individual basis. More-
over, anticoagulation has been shown to facilitate blood loss37 and,
therefore, levels of hemoglobin should be monitored more closely
starting D1. The aforementioned ‘at risk’ patient groups (as deﬁned
in Table 6) require closer observation due to greater variance in
physiology (such as patients with renal or cardiovascular disease)
and coagulation (patients taking anticoagulation therapy).
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